ARVO Foundation / Pfizer Ophthalmics / Carl Camras Translational Research Awards
Thanks to a generous donation from Pfizer Ophthalmics, the ARVO Foundation for Eye Research has established the ARVO Foundation/Pfizer Ophthalmics/Carl Camras Translational Research Awards in honor of Carl B. Camras, MD.
Dr. Camras was highly respected for his work as a glaucoma specialist and a research scientist. He was most widely recognized for developing prostaglandin analogues for the treatment of elevated IOP in patients with glaucoma. During his distinguished career, he took a personal interest in developing the next generation of eye and vision researchers.
Pfizer Ophthalmics is dedicated to making a difference in the lives of patients with eye disorders and committed to supporting ophthalmic research. Its mission is to become the most valued partner in ophthalmics. The ARVO Foundation/Pfizer Ophthalmics/Carl Camras Translational Research Award demonstrates this unwavering commitment.
Up to three awards of $10,000 each will be presented annually.
Nominees must meet the following criteria:
- Early career researchers, who are no more than 45 years old at the time of nomination.
- Exhibit excellence in research and their fundamental scientific discoveries, concepts and novel technologies
- The discovery or observation must have led to, or have the promise of leading to, clinical applications
Nominations must be submitted online. Recipients will be notified June 2012, and the awards will be presented at 2013 ARVO Annual Meeting keynote Session in Seattle, Washington.